Ollin Biosciences, Inc. — Form D

Ollin Biosciences, Inc. of AUSTIN, TX, a company, filed a Form D exempt-offering notice with the SEC on 2026-06-24. The offering totals $330.0M, of which $156.2M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2026-06-24
• Form: D
• Accession: 0002141184-26-000002
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $330.0M
• Amount sold: $156.2M
• Remaining: $173.8M
• Investors: 32
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-588459

Issuer

• Name: Ollin Biosciences, Inc.
• CIK: 0002141184
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 1250 S. CAPITAL OF TEXAS HWY BUILDING 3, SUITE 400, AUSTIN, TX, 78746
• Phone: 512-885-4957

Officers, directors & promoters (6)

More

• CIK 2141184 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search